483
Swati Spentose Private LimitedFDA 483 - Swati Spentose Private Limited - May 31, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Swati Spentose Private Limited, an API Non-Sterile Drug Substance Manufacturer in Vapi, India, was cited with two observations during an FDA inspection. The inspection revealed significant deficiencies in employee training, specifically for QC laboratory reviewers, and a systemic failure within the quality control unit to follow approved testing procedures, leading to a high number of recurring human errors.
- Office
- Office of Partnerships
- Person
Open in Dashboard
ID · afee216b-b606-4562-9450-cbf9b1a85d9b